摘要
目的:探讨分析应用美托洛尔联合胺碘酮治疗充血性心力衰竭合并快速性心律失常的临床疗效。方法:选取2012年11月至2014年11月间我院收治的患有充血性心力衰竭合并快速性心律失常的患者80例作为研究对象,采用随机数字表法将其分为对照组(40例)和试验组(40例),单纯使用胺碘酮为对照组患者进行治疗,联合使用胺碘酮和美托洛尔为试验组患者进行治疗,观察对比两组患者的临床疗效,并将对比的结果及两组患者的临床资料进行回顾性的分析。结果:在对照组40例患者中,临床疗效判定等级为显效的患者有15例(占患者总数的37.50%),为有效的患者有10例(占患者总数的25.00%),为无效的患者有15例(占患者总数的37.50%),治疗的总有效率为62.50%;在试验组40例患者中,临床疗效判定等级为显效的患者有21例(占患者总数的52.50%),为有效的患者有15例(占患者总数的37.50%),为无效的患者有4例(占患者总数的10.00%),治疗的总有效率为90.00%。试验组患者的临床疗效明显优于对照组患者,差异显著(P<0.05),具有统计学意义。结论:应用美托洛尔联合胺碘酮治疗充血性心力衰竭合并快速性心律失常的临床疗效显著,值得在临床上推广应用。
Objective: congestive heart failure patients with tachyarrhythmias merger metoprolol and amiodarone effects of combination therapy were analyzed and discussed. Methods: November 2012 to November 2014 80 cases treated in our hospital patients with congestive heart failure were randomly divided into experimental group and control group 40 cases, initial treatment for two groups of patients in bed, oxygen and limit salt and other operations, the control group patients on the basis of conventional therapy with amiodarone, the test group of patients treated on the basis of the control group on the use of metoprolol treatment, the efficacy of the two groups were carried out after a month of treatment comparisons. Results: The total effective rate of patients (90.00%) was significantly better than the control group of patients overall response rate (62.50%), significant (P <0.05) statistically. Conclusion: The treatment of congestive heart failure and tachyarrhythmia treatment effect using metoprolol and amiodarone to be significantly better than amiodarone alone and cheap, good safety, most patients are more satisfied and should be introduced.
